An open-lab, multicenter, prospective study for reduced dosage Decitabine in subjects with Myelodysplastic Syndromes-Refractory Anemia with Excess Blasts (MDS-RAEB)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2017
This article has no abstract
Epistemonikos ID: 715e5c6ecb2725005a13bde37d544edb836ef93b
First added on: Apr 16, 2025